Clinical Trial Update: AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing AFS to AHC for necrotizing fasciitis is active but not recruiting, sponsored by Kerecis Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Fasciitis

Drugs mentioned

• AFS
• AHC

Snippet

Sponsor: Kerecis Ltd. | Conditions: Necrotizing Fasciitis | Phase 4 | Status: ACTIVE_NOT_RECRUITING